Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals

Life Sciences

Volumn 88, Issue 21-22, 2011, Pages 948-952

  Lucas, Gregory M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; Adherence; HIV infection; Substance abuse

Indexed keywords

BUPRENORPHINE PLUS NALOXONE; METHADONE;

ADDICTION; CD4 LYMPHOCYTE COUNT; COMORBIDITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE TRANSMISSION; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; META ANALYSIS (TOPIC); MORTALITY; MYOPIA; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PATIENT COMPLIANCE; PATIENT COUNSELING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUBSTANCE ABUSE; TREATMENT OUTCOME; VIRUS LOAD;

ANTI-HIV AGENTS; DIRECTLY OBSERVED THERAPY; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 79956192748     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.09.025     Document Type: Review

References (65)

1. F.L. Altice, F. Mostashari, and G.H. Friedland Trust and the acceptance of and adherence to antiretroviral therapy J Acquir Immune Defic Syndr 28 1 2001 47 58 (Pubitemid 33104527)
2. F.L. Altice, D.S. Maru, R.D. Bruce, S.A. Springer, and G.H. Friedland Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial Clin Infect Dis 45 6 2007 770 778 (Pubitemid 47378892)
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders Fourth Edition 1994 Washington DC American Psychiatric Association
4. J.H. Arnsten, P.A. Demas, R.W. Grant, M.N. Gourevitch, H. Farzadegan, and A.A. Howard Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users J Gen Intern Med 17 5 2002 377 381 (Pubitemid 34626108)
5. D.R. Bangsberg, L.M. Mundy, and J.P. Tulsky Expanding directly observed therapy: tuberculosis to human immunodeficiency virus Am J Med 110 8 2001 664 666 (Pubitemid 32510697)
6. J.G. Bartlett, B.M. Branson, K. Fenton, B.C. Hauschild, V. Miller, and K.H. Mayer Opt-out testing for human immunodeficiency virus in the United States: progress and challenges JAMA, J Am Med Assoc 300 8 2008 945 951
7. M.K. Baum, C. Rafie, S. Lai, S. Sales, B. Page, and A. Campa Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users J Acquir Immune Defic Syndr 50 1 2009 93 99
8. B.M. Branson, H.H. Handsfield, M.A. Lampe, R.S. Janssen, A.W. Taylor, and S.B. Lyss Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings MMWR Recomm Rep 55 RR-14 2006 1 17
9. M.P. Carrieri, J.P. Moatti, D. Vlahov, Y. Obadia, C. Reynaud-Maurupt, and M. Chesney Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group J Epidemiol Community Health 53 1 1999 4 8 (Pubitemid 29012343)
10. D.D. Celentano, D. Vlahov, S. Cohn, V.M. Shadle, O. Obasanjo, and R.D. Moore Self-reported antiretroviral therapy in injection drug users [see comments] JAMA, J Am Med Assoc 280 6 1998 544 546
11. D.D. Celentano, N. Galai, A.K. Sethi, N.G. Shah, S.A. Strathdee, and D. Vlahov Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users AIDS 15 13 2001 1707 1715 (Pubitemid 32918126)
12. G. Chander, B. Lau, and R.D. Moore Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection J Acquir Immune Defic Syndr 43 4 2006 411 417 (Pubitemid 44737097)
13. C.P. Chaulk, and V.A. Kazandjian Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel [published erratum appears in JAMA 1998 Jul 8; 280(2):134] JAMA, J Am Med Assoc 279 12 1998 943 948 (Pubitemid 28136084)
14. L.W. Cheever Engaging HIV-infected patients in care: their lives depend on it Clin Infect Dis 44 11 2007 1500 1502 (Pubitemid 46801596)
15. J.A. Cook, J.K. Burke-Miller, M.H. Cohen, R.L. Cook, D. Vlahov, and T.E. Wilson Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women AIDS 22 11 2008 1355 1363
16. L.A. Cooper A 41-year-old African American man with poorly controlled hypertension: review of patient and physician factors related to hypertension treatment adherence JAMA, J Am Med Assoc 301 12 2009 1260 1272
17. M. Egger, M. May, G. Chene, A.N. Phillips, B. Ledergerber, and F. Dabis Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies Lancet 360 9327 2002 119 129 (Pubitemid 34786200)
18. D.A. Fiellin, and P.G. O'Connor Office-based treatment of opioid-dependent patients N Engl J Med 347 11 2002 817 823 (Pubitemid 34988341)
19. T.P. Flanigan, and J.A. Mitty The good, the bad, and the ugly: providing highly active antiretroviral therapy when it is most difficult Clin Infect Dis 42 11 2006 1636 1638
20. N. Ford, J.B. Nachega, M.E. Engel, and E.J. Mills Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials Lancet 374 9707 2009 2064 2071
21. B. Gerbert, B.T. Maguire, T. Bleecker, T.J. Coates, and S.J. McPhee Primary care physicians and AIDS. Attitudinal and structural barriers to care [see comments] JAMA, J Am Med Assoc 266 20 1991 2837 2842
22. T.P. Giordano, A.L. Gifford, A.C. White Jr., M.E. Suarez-Almazor, L. Rabeneck, and C. Hartman Retention in care: a challenge to survival with HIV infection Clin Infect Dis 44 11 2007 1493 1499 (Pubitemid 46801595)
23. E.T. Golub, J.A. Astemborski, D.R. Hoover, J.C. Anthony, D. Vlahov, and S.A. Strathdee Psychological distress and progression to AIDS in a cohort of injection drug users J Acquir Immune Defic Syndr 32 4 2003 429 434 (Pubitemid 36363158)
24. R. Gross, C. Tierney, A. Andrade, C. Lalama, S. Rosenkranz, and S.H. Eshleman Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial Arch Intern Med 169 13 2009 1224 1232
25. J.R. Ickovics, M.E. Hamburger, D. Vlahov, E.E. Schoenbaum, P. Schuman, and R.J. Boland Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study JAMA, J Am Med Assoc 285 11 2001 1466 1474 (Pubitemid 32221895)
26. M. Javanbakht, P. Prosser, T. Grimes, M. Weinstein, and C. Farthing Efficacy of an individualized adherence support program with contingent reinforcement among nonadherent HIV-positive patients: results from a randomized trial J Int Assoc Physicians AIDS Care Chic Ill 5 4 2006 143 150
27. F. Kapadia, D. Vlahov, Y. Wu, M.H. Cohen, R.M. Greenblatt, and A.A. Howard Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women Am J Drug Alcohol Abuse 34 2 2008 161 170 (Pubitemid 351302169)
28. R. Kavasery, N. Galai, J. Astemborski, G.M. Lucas, D.D. Celentano, and G.D. Kirk Nonstructured treatment interruptions among injection drug users in Baltimore MD J Acquir Immune Defic Syndr 50 4 2009 360 366
29. M.M. Kitahata, S.J. Gange, A.G. Abraham, B. Merriman, M.S. Saag, and A.C. Justice Effect of early versus deferred antiretroviral therapy for HIV on survival N Engl J Med 360 18 2009 1815 1826
30. G. Loewenstein, T. Brennan, and K.G. Volpp Asymmetric paternalism to improve health behaviors JAMA 298 20 2007 2415 2417 (Pubitemid 350190784)
31. G.M. Lucas, R.E. Chaisson, and R.D. Moore Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions Ann Intern Med 131 2 1999 81 87 (Pubitemid 29340558)
32. G.M. Lucas, L.W. Cheever, R.E. Chaisson, and R.D. Moore Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection J Acquir Immune Defic Syndr 27 3 2001 251 259 (Pubitemid 32661966)
33. G.M. Lucas, C.W. Flexner, and R.D. Moore Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden? Aids Patient Care STDS 16 11 2002 527 535 (Pubitemid 35364804)
34. G.M. Lucas, M. Griswold, K.A. Gebo, J. Keruly, R.E. Chaisson, and R.D. Moore Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy Am J Epidemiol 163 5 2006 412 420
35. G.M. Lucas, A. Chaudhry, J. Hsu, T. Woodson, B. Lau, and Y. Olsen Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: a randomized trial Ann Intern Med 152 11 2010 704 711
36. G.E. Macalino, J.W. Hogan, J.A. Mitty, L.B. Bazerman, A.K. Delong, and H. Loewenthal A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users AIDS 21 11 2007 1473 1477 (Pubitemid 46988008)
37. T.M. Marteau, R.E. Ashcroft, and A. Oliver Using financial incentives to achieve healthy behaviour BMJ 338 2009 b1415
38. B.M. Mathers, L. Degenhardt, B. Phillips, L. Wiessing, M. Hickman, and S.A. Strathdee Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review Lancet 372 9651 2008 1733 1745
39. B.M. Mathers, L. Degenhardt, H. Ali, L. Wiessing, M. Hickman, and R.P. Mattick HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage Lancet 375 9719 2010 1014 1028
40. J.P. Moatti, M.P. Carrieri, B. Spire, J.A. Gastaut, J.P. Cassuto, and J. Moreau Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group AIDS 14 2 2000 151 155 (Pubitemid 30116440)
41. R.D. Moore, J.C. Keruly, and R.E. Chaisson Differences in HIV disease progression by injecting drug use in HIV-infected persons in care J Acquir Immune Defic Syndr 35 1 2004 46 51 (Pubitemid 38044781)
42. M. Nacher, A. Adenis, M. Hanf, L. Adriouch, V. Vantilcke, and G.M. El Crack cocaine use increases the incidence of AIDS-defining events in French Guiana AIDS 23 16 2009 2223 2226
43. B.A. Olatosi, J.C. Probst, C.H. Stoskopf, A.B. Martin, and W.A. Duffus Patterns of engagement in care by HIV-infected adults: South Carolina, 2004-2006 AIDS 23 6 2009 725 730
44. A. Palepu, M.W. Tyndall, R. Joy, T. Kerr, E. Wood, and N. Press Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy Drug Alcohol Depend 84 2 2006 188 194 (Pubitemid 44119095)
45. D.L. Paterson, S. Swindells, J. Mohr, M. Brester, E.N. Vergis, and C. Squier Adherence to protease inhibitor therapy and outcomes in patients with HIV infection Ann Intern Med 133 1 2000 21 30 (Pubitemid 30432540)
46. M.O. Rigsby, M.I. Rosen, J.E. Beauvais, J.A. Cramer, P.M. Rainey, and S.S. O'Malley Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention J Gen Intern Med 15 12 2000 841 847 (Pubitemid 32011833)
47. M.I. Rosen, K. Dieckhaus, T.J. McMahon, B. Valdes, N.M. Petry, and J. Cramer Improved adherence with contingency management Aids Patient Care STDS 21 1 2007 30 40
48. U. Sambamoorthi, L.A. Warner, S. Crystal, and J. Walkup Drug abuse, methadone treatment, and health services use among injection drug users with AIDS Drug Alcohol Depend 60 1 2000 77 89 (Pubitemid 30255988)
49. H. Schmidt, K. Voigt, and D. Wikler Carrots, sticks, and health care reform - problems with wellness incentives N Engl J Med 362 2 2010 e3
50. J.L. Sorensen, N.A. Haug, K.L. Delucchi, V. Gruber, E. Kletter, and S.L. Batki Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial Drug Alcohol Depend 88 1 2007 54 63 (Pubitemid 46400307)
51. M. Stitzer, and N. Petry Contingency management for treatment of substance abuse Annu Rev Clin Psychol 2 411-34 2006 411 434 (Pubitemid 43799812)
52. S.A. Strathdee, A. Palepu, P.G. Cornelisse, B. Yip, M.V. O'Shaughnessy, and J.S. Montaner Barriers to use of free antiretroviral therapy in injection drug users [see comments] JAMA, J Am Med Assoc 280 6 1998 547 549 (Pubitemid 28377675)
53. R.C. Thornton The demand for, and impact of, learning HIV status Am Econ Rev 98 5 2008 1829 1863
54. G.J. Treisman, A.F. Angelino, and H.E. Hutton Psychiatric issues in the management of patients with HIV infection JAMA 286 22 2001 2857 2864 (Pubitemid 33126929)
55. A. Umbricht-Schneiter, D.H. Ginn, K.M. Pabst, and G.E. Bigelow Providing medical care to methadone clinic patients: referral vs on-site care [see comments] Am J Public Health 84 2 1994 207 210 (Pubitemid 24138452)
56. K.G. Volpp, L.K. John, A.B. Troxel, L. Norton, J. Fassbender, and G. Loewenstein Financial incentive-based approaches for weight loss: a randomized trial JAMA 300 22 2008 2631 2637
57. K.G. Volpp, M.V. Pauly, G. Loewenstein, and D. Bangsberg P4P4P: an agenda for research on pay-for-performance for patients Health Aff Millwood 28 1 2009 206 214
58. K.G. Volpp, A.B. Troxel, M.V. Pauly, H.A. Glick, A. Puig, and D.A. Asch A randomized, controlled trial of financial incentives for smoking cessation N Engl J Med 360 7 2009 699 709
59. C. Weisner, J. Mertens, S. Parthasarathy, C. Moore, and Y. Lu Integrating primary medical care with addiction treatment: a randomized controlled trial JAMA, J Am Med Assoc 286 14 2001 1715 1723 (Pubitemid 33010257)
60. M.L. Willenbring, and D.H. Olson A randomized trial of integrated outpatient treatment for medically ill alcoholic men Arch Intern Med 159 16 1999 1946 1952 (Pubitemid 29424716)
61. A.R. Wohl, W.H. Garland, R. Valencia, K. Squires, M.D. Witt, and A. Kovacs A randomized trial of directly administered antiretroviral therapy and adherence case management intervention Clin Infect Dis 42 11 2006 1619 1627
62. E. Wood, J.S. Montaner, B. Yip, M.W. Tyndall, M.T. Schechter, and M.V. O'Shaughnessy Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users CMAJ 169 7 2003 656 661 (Pubitemid 37266973)
63. E. Wood, R.S. Hogg, T. Kerr, A. Palepu, R. Zhang, and J.S. Montaner Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naive HIV-infected injection drug users AIDS 19 8 2005 837 839 (Pubitemid 40834758)
64. E. Wood, R.S. Hogg, V.D. Lima, T. Kerr, B. Yip, and B.D. Marshall Highly active antiretroviral therapy and survival in HIV-infected injection drug users JAMA, J Am Med Assoc 300 5 2008 550 554
65. World Health Organization United Nations Office on Drugs and Crime Joint United Nations Programme on HIV/AIDS Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users Available at http://www.who.int/hiv/pub/idu/en 2009